Stricter Regulations on GLP-1 Drugs to Curb Health Risks
Published on: April 1, 2026, 3:47 p.m. | Source: Devdiscourse
The Indian government is intensifying regulatory surveillance over GLP-1 drugs used for diabetes and obesity due to concerns about unauthorized sales and side effects. These medications, requiring prescription, have been linked to severe health risks if misused. Inspections and stricter enforcement are being implemented to prevent malpractices.
